Analyze Portfolio
Nasdaq · Financials

CME GROUP INC. (CME)

As-reported financials and recent SEC filings for CME GROUP INC., latest fiscal period FY2025. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About CME GROUP INC.

CME Group Inc. operates as a financial exchange company providing clearing and transaction services for various asset classes including interest rates, equities, foreign exchange, agricultural commodities, energy, and metals. It offers market data and information services to its clients, which include traders, investors, and financial institutions. The company facilitates trading and risk management through its electronic trading platforms and clearinghouses.

Snapshot

Revenue
$6.52B
Revenue growth (YoY)
6.4%
Net income
$4.07B
Diluted EPS
$11.16
Gross margin
Operating margin
64.9%
Net margin
62.5%
FCF margin
64.3%
ROE
14.2%
P/E (TTM)
21.6×
Market cap
$91.82B
Debt / equity

Fundamentals are from SEC filings. P/E and market cap are derived from recent market prices, refreshed on a rolling basis (typically within the past week).

What changed at Cme Group

  • Revenue grew 6.4% to $6.5B in FY2025, slower than the 9.9% the year before.
  • Operating margin is 64.9% in FY2025, +8.5 pp against 56.4% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $1.7B, up 0.8% from Q2 FY2025.
  • Free cash flow was $4.2B in FY2025, 64.3% of revenue.
  • Net income rose 15.5% to $4.1B in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Cme Group’s fundamentals sit among the 424 Financials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Operating margin64.9%
Highest of 147
Net margin62.5%
99th percentile of 378
FCF margin64.3%
96th percentile of 273
Revenue growth (YoY)+6.4%
36th percentile of 420
ROE14.2%
74th percentile of 375
P/E (TTM)21.6×
76th percentile of 316
Short interest1.88d
13th percentile of 419

Cme Group’s operating margin of 64.9% is the highest of the 147 Financials companies reporting it. Cme Group’s net margin of 62.5% ranks in the 99th percentile of the 378 Financials companies reporting it. Cme Group’s FCF margin of 64.3% ranks in the 96th percentile of the 273 Financials companies reporting it.

2 open-market insider buys totaling $78,186 in the last 90 days, against 3 sales totaling $12.2M. For context, about 16% of companies in the universe saw any open-market insider buying in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 3 of the superinvestors we track (plus 7 quant / multi-strat books), based on each investor’s most recent 13F (latest Q1 2026).

Conviction investors
3
+7 quant / multi-strat
Initiated / added
2
0 new, 2 added
Reduced / exited
7
7 trimmed, 0 exited
Combined position
$1.23B
reported long value
InvestorAs ofPosition valueSharesChange
AQR Capital ManagementquantQ1 2026$585.4M2.0MReduced
Two Sigma InvestmentsquantQ1 2026$340.1M1.2MAdded
Citadel AdvisorsquantQ1 2026$110.4M374.0KReduced
Millennium ManagementquantQ1 2026$49.6M168.0KReduced
D. E. ShawquantQ1 2026$40.7M137.9KReduced
Gotham Asset ManagementQ1 2026$39.2M132.7KReduced
Point72 Asset ManagementquantQ1 2026$26.6M90.0KReduced
Markel GroupQ1 2026$14.7M49.8KAdded
Renaissance TechnologiesquantQ1 2026$10.3M34.8KReduced
Soros Fund ManagementQ1 2026$8.9M30.0KHeld

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
2
1 insider
Bought (90d)
$78K
open-market value
Sells (90d)
3
$12.2M
Signal
Net selling
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-06-25
filed 2026-06-29
SHEPARD WILLIAM RDirectorBuy325$230.57$75K
2026-06-25
filed 2026-06-29
SHEPARD WILLIAM RDirectorBuy14$230.57$3K
2026-05-18
filed 2026-05-19
Piell Hilda HarrisSr MD & Chief HR OfficerSell5.8K$304.63$1.8M
2026-05-15
filed 2026-05-18
DUFFY TERRENCE AChairman and CEOSell26.0K$298.14$7.8M
2026-05-15
filed 2026-05-18
DUFFY TERRENCE AChairman and CEOSell9.0K$299.58$2.7M

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
5.8M
settled 2026-07-15
Change vs prior
-2.9%
vs previous settlement
Days to cover
1.88
at avg daily volume
Avg daily volume
3.1M
FINRA reported
SettlementShares shortChangeDays to cover
2026-07-155.8M-2.9%1.88
2026-06-306.0M+15.3%1.24
2026-06-155.2M+14.1%1.25
2026-05-294.6M-4.5%1.70
2026-05-154.8M+16.5%2.09
2026-04-304.1M-14.6%1.68
2026-04-154.8M+2.3%2.15
2026-03-314.7M-15.6%2.31

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$6.52B$6.13B$5.58B$5.02B$4.69B
Gross profit
Operating income$4.23B$3.93B$3.44B$3.02B$2.65B
Net income$4.07B$3.53B$3.23B$2.69B$2.64B
Diluted EPS$11.16$9.67$8.86$7.40$7.29

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Balance sheet (as reported)

 FY2025FY2024FY2023FY2022FY2021
Cash and equivalents$4.42B$2.89B$2.91B$2.72B$2.83B
Current assets$165.36B$103.03B$94.89B$139.08B$161.76B
Total assets$198.42B$137.45B$129.71B$174.18B$196.78B
Current liabilities$160.30B$102.31B$93.42B$137.69B$160.40B
Long-term debt
Total liabilities$169.70B$110.96B$102.97B$147.30B$169.38B
Total equity$28.73B$26.49B$26.74B$26.88B$27.40B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$4.28B$3.69B$3.45B$3.06B$2.40B
Capital expenditure$83.5M$94.0M$76.4M$89.7M$127.2M
Free cash flow$4.19B$3.60B$3.38B$2.97B$2.28B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full methodology.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$1.71B0.8%$1.04B$2.88
Q1 FY2026$1.88B14.5%$1.15B$3.18
Q4 FY2025$1.65B8.1%$3.24
Q3 FY2025$1.54B-3.0%$908.0M$2.49
Q2 FY2025$1.69B10.4%$1.03B$2.81
Q1 FY2025$1.64B10.4%$956.2M$2.62
Q4 FY2024$1.53B6.0%$2.40
Q3 FY2024$1.58B18.4%$912.8M$2.50

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNasdaq
SectorFinancials
SIC industrySecurity & Commodity Brokers, Dealers, Exchanges & Services
Fiscal year endDecember 31
Latest fiscal periodFY2025
SEC filings since2018
SEC CIK1156375

Recent SEC filings

10-K2026-02-26
View on EDGAR →
10-K2025-02-27
View on EDGAR →
10-Q2026-07-24
View on EDGAR →
10-Q2026-04-24
View on EDGAR →
10-Q2025-10-24
View on EDGAR →
10-Q2025-07-25
View on EDGAR →
8-K2026-07-22
View on EDGAR →
8-K2026-06-17
View on EDGAR →

Largest Financials peers

All Financials companies →

CME head to head

Monitor CME

Get an alert when Cme Group files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor CME free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.